Academic Content and Language Evaluation of This Article
Citation of this article
Corresponding Author of This Article
Research Domain of This Article
Article-Type of This Article
Open-Access Policy of This Article
Times Cited Counts in Google of This Article
Number of Hits and Downloads for This Article
- Total Article Views (7904)
All Articles published online
|
Publishing Process of This Article
|
Dec 27, 2014 (publication date) through Nov 22, 2024
Times Cited of This Article
Journal Information of This Article
Publication Name
World Journal of Hepatology
ISSN
1948-5182
Publisher of This Article
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
| For: | Ikura Y. Transitions of histopathologic criteria for diagnosis of nonalcoholic fatty liver disease during the last three decades. World J Hepatol 2014; 6(12): 894-900 [PMID: 25544876 DOI: 10.4254/wjh.v6.i12.894] |
|---|---|
| URL: | https://www.wjgnet.com/1007-9327/full/v6/i12/894.htm |
| Number | Citing Articles |
| 1 |
Jian-Jun Gao, Zhen-Yan Shi, Ju-Feng Xia, Yoshinori Inagaki, Wei Tang. Sorafenib-based combined molecule targeting in treatment of hepatocellular carcinoma. World Journal of Gastroenterology 2015; 21(42): 12059-12070 doi: 10.3748/wjg.v21.i42.12059
|
| 2 |
Pierre Bedossa, Keyur Patel. Biopsy and Noninvasive Methods to Assess Progression of Nonalcoholic Fatty Liver Disease. Gastroenterology 2016; 150(8): 1811 doi: 10.1053/j.gastro.2016.03.008
|
| 3 |
Karen C. M. Moraes, Jacques Montagne. Drosophila melanogaster: A Powerful Tiny Animal Model for the Study of Metabolic Hepatic Diseases. Frontiers in Physiology 2021; 12 doi: 10.3389/fphys.2021.728407
|
| 4 |
Suzan Schwertheim, Malek Alhardan, Paul P. Manka, Jan-Peter Sowa, Ali Canbay, Hartmut H.-J. Schmidt, Hideo A. Baba, Julia Kälsch. Higher pNRF2, SOCS3, IRF3, and RIG1 Tissue Protein Expression in NASH Patients versus NAFL Patients: pNRF2 Expression Is Concomitantly Associated with Elevated Fasting Glucose Levels. Journal of Personalized Medicine 2023; 13(7): 1152 doi: 10.3390/jpm13071152
|
| 5 |
N V Denisov, V B Grinevich, E V Chernetcova, L A Kornouchova, U A Kravchuk, S A Partsernyak, A N Mironenko. NON-ALCOHOLIC FATTY LIVER DISEASE AS A NEW COMPONENT OF THE METABOLIC SYNDROME IN THE LIGHT OF MODERN METHODS OF DIAGNOSIS. HERALD of North-Western State Medical University named after I.I. Mechnikov 2017; 9(1): 34 doi: 10.17816/mechnikov20179134-41
|
| 6 |
Dayun Liu, Yibiao Huang, Wenjuan Nie, Jiaxuan Zhang, Lei Deng. SMALF: miRNA-disease associations prediction based on stacked autoencoder and XGBoost. BMC Bioinformatics 2021; 22(1) doi: 10.1186/s12859-021-04135-2
|
| 7 |
Letícia F Ramos, Caio M Silva, Camila C Pansa, Karen C M Moraes. Non-alcoholic fatty liver disease: molecular and cellular interplays of the lipid metabolism in a steatotic liver. Expert Review of Gastroenterology & Hepatology 2021; 15(1): 25 doi: 10.1080/17474124.2020.1820321
|
| 8 |
Suzan Schwertheim, Julia Kälsch, Holger Jastrow, Christoph Matthias Schaefer, Sarah Theurer, Saskia Ting, Ali Canbay, Heiner Wedemeyer, Kurt Werner Schmid, Hideo Andreas Baba. Characterization of two types of intranuclear hepatocellular inclusions in NAFLD. Scientific Reports 2020; 10(1) doi: 10.1038/s41598-020-71646-y
|
| 9 |
Wei Qiu, Guangyi Wang, Xiaodong Sun, Junfeng Ye, Feng Wei, Xiaoju Shi, Guoyue Lv. The involvement of cell surface nucleolin in the initiation of CCR6 signaling in human hepatocellular carcinoma. Medical Oncology 2015; 32(3) doi: 10.1007/s12032-015-0530-1
|
| 10 |
Xiang Qiu, Dan-Hong Gao, Xiao Xiang, Yu-Fang Xiong, Teng-Shi Zhu, Lie-Gang Liu, Xiu-Fa Sun, Li-Ping Hao. Ameliorative effects of lutein on non-alcoholic fatty liver disease in rats. World Journal of Gastroenterology 2015; 21(26): 8061-8072 doi: 10.3748/wjg.v21.i26.8061
|
| 11 |
V. T. Ivashkin, M. V. Maevskaya, M. S. Zharkova, Yu. V. Kotovskaya, O. N. Tkacheva, E. A. Troshina, M. V. Shestakova, I. V. Maev, V. V. Breder, N. I. Gheivandova, V. L. Doshchitsin, E. N. Dudinskaya, E. V. Ershova, Kh. B. Kodzoeva, K. A. Komshilova, N. V. Korochanskaya, A. Yu. Mayorov, E. E. Mishina, M. Yu. Nadinskaya, I. G. Nikitin, N. V. Pogosova, A. I. Tarzimanova, M. Sh. Shamkhalova. Clinical Practice Guidelines of the Russian Scientific Liver Society, Russian Gastroenterological Association, Russian Association of Endocrinologists, Russian Association of Gerontologists and Geriatricians and National Society for Preventive Cardiology on Diagnosis and Treatment of Non-Alcoholic Liver Disease. Russian Journal of Gastroenterology, Hepatology, Coloproctology 2022; 32(4): 104 doi: 10.22416/1382-4376-2022-32-4-104-140
|
| 12 |
Alessandra Stacchiotti, Gaia Favero, Antonio Lavazza, Igor Golic, Marija Aleksic, Aleksandra Korac, Luigi Fabrizio Rodella, Rita Rezzani, Anna Alisi. Hepatic Macrosteatosis Is Partially Converted to Microsteatosis by Melatonin Supplementation in ob/ob Mice Non-Alcoholic Fatty Liver Disease. PLOS ONE 2016; 11(1): e0148115 doi: 10.1371/journal.pone.0148115
|
| 13 |
Jitka Starekova, Diego Hernando, Perry J. Pickhardt, Scott B. Reeder. Quantification of Liver Fat Content with CT and MRI: State of the Art. Radiology 2021; 301(2): 250 doi: 10.1148/radiol.2021204288
|
| 14 |
V. T. Ivashkin, Marina V. Mayevskaya, Ch. S. Pavlov, I. N. Tikhonov, Ye. N. Shirokova, A. O. Buyeverov, O. M. Drapkina, Yu. O. Shulpekova, V. V. Tsukanov, S. N. Mammayev, I. V. Mayev, L. K. Palgova. Diagnostics and treatment of non-alcoholic fatty liver disease: clinical guidelines of the Russian Scientific Liver Society and the Russian gastroenterological association. Russian Journal of Gastroenterology, Hepatology, Coloproctology 2016; 26(2): 24 doi: 10.22416/1382-4376-2016-26-2-24-42
|